News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 397–432
- Matches
- 6695
- Sources here
- 22
- Companies here
- 34
Search results
Stored financial headlines
Active search
6695 matching headlines
Ticker or company: IFMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours
Thermo Fisher Scientific and KYAN Technologies have signed an MoU to advance functional precision oncology for solid tumours. The collaboration will use patient-derived tumoroid models, functional drug-response screening, and genomic analysis to gather patient-relevant data across various cancers, aiming to improve therapeutic decision-making. They …
TMO
main company
Sharemaestro market context
Trend signal started
52 weeks +18.1%
Why SELLAS (SLS) Posted a Wider Net Loss but a Narrower Per-Share Loss This Quarter
SELLAS Life Sciences Group (SLS) reported a wider net loss in Q2 2026 but a narrower loss per share, driven by increasing expenses related to late-stage oncology programs. The company's investment narrative continues to revolve around the success of its Phase 3 REGAL trial …
SLS
main company
Sharemaestro market context
Trend signal active
52 weeks +569.1%
LifeMD, Inc. (NASDAQ:LFMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages
LifeMD, Inc. (NASDAQ:LFMD) has received a "Moderate Buy" consensus rating from ten brokerages, with an average 12-month price target of $7.57. Despite this, the company reported a slight miss on quarterly earnings and revenue expectations, posting a loss of $0.16 per share and $47.28 …
LFMD
main company
Sharemaestro market context
Price below Trend Line
52 weeks -45.5% · Next-week setup negative 42.8%
Sun Life (SLF) Q2 2026 Earnings Call Transcript
Sun Life Financial (SLF) reported strong Q2 2026 results with double-digit underlying EPS growth and increased earnings across all business segments, including record income in Canada and significant growth in Asia and the U.S. medical stop loss market. The company highlighted advancements in AI, …
SLF
main company
Sharemaestro market context
Trend signal active
52 weeks +44.0%
Ziff Davis (ZD) Q2 2026 Earnings Call Transcript
Image source: The Motley Fool. DATE Aug. 7, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Financial Officer - Bret RichterChief Executive Officer - Vivek Shah TAKEAWAYS Revenue -- $286.7 million, representing a 2.7% decrease across four reportable segments compared to the prior year.Adjusted …
ZD
main company
Sharemaestro market context
Trend signal active
52 weeks +44.9%
GRIFFON CORP SEC Filing (Aug 13, 2026)
This article details a Form 144 SEC filing by Griffon Corp (GFF) on August 13, 2026, which outlines a proposed sale of 3,500 shares of common stock by an individual. The shares were acquired through an open market purchase on December 21, 2021, and …
GFF
main company
Sharemaestro market context
Trend signal active
52 weeks +39.3%
MetLife’s Q2 Earnings Call: Our Top 5 Analyst Questions
MetLife's Q2 Earnings Call: Our Top 5 Analyst Questions MetLife's second quarter results were marked by broad-based earnings growth, with market participants rewarding the company's performance as shares rose notably after the announcement. Management attributed the positive momentum to strong underwriting across all segments, …
Sharemaestro market context Trend signal active 52 weeks +15.9%Ziff Davis CAO Lori Tansley sells $76,664 in company stock
Lori A. Tansley, Chief Accounting Officer at Ziff Davis, Inc. (NASDAQ:ZD), sold 1,400 shares of company stock for $76,664 on August 12, 2026. This insider sale occurred while Ziff Davis stock was trading near its 52-week high, following an 83% surge in the past …
ZD
main company
Sharemaestro market context
Trend signal active
52 weeks +44.9%
WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares
WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe sold 12,700 shares of the company's stock for approximately $67,183. The sale occurred on August 12th when shares were trading at $5.29. Following the transaction, WVE shares fell to $5.20, near their 12-month low, and the company …
WVE
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.7%
Insider Selling: WAVE Life Sciences (NASDAQ:WVE) Director Sells $42,070.00 in Stock
WAVE Life Sciences (NASDAQ:WVE) Director Heidi Wagner sold 7,000 shares of the company's stock for $42,070, reducing her position by 13.48%. The sale occurred amidst weak trading and quarterly results, with WVE shares near their 52-week low and the company reporting a loss and …
WVE
main company
Sharemaestro market context
Price below Trend Line
52 weeks -46.7%
Insider Activity Alert: Banc of California's CRO Parts with 6,000 Shares
Banc of California's Chief Risk Officer, Olivia I. Lindsay, sold 6,000 shares of the company's common stock for $117,000 on August 4, 2026. This transaction leaves Lindsay with 32,842 shares, valued at over $641,000, and is considered a routine move. The article highlights Banc …
BANC
main company
Sharemaestro market context
Trend signal active
52 weeks +24.1%